All News #Library
Others
Medeor Therapeutics to Provide Interim Results of Ph3 Mercury Study of MDR-101
20 May 2021 //
BUSINESSWIRE
Medeor Therapeutics to Provide Interim Results of Ph3 Mercury Study of MDR-101
20 May 2021 //
BUSINESSWIRE
Medeor Completes Enrollment and Transplantation for Pivotal Trial of MDR-101
12 May 2021 //
BUSINESSWIRE
Medeor Completes Enrollment & Transplantation for Pivotal Trial of MDR-101
12 May 2021 //
BIOSPACE

Market Place
Sourcing Support